Emory University is a leading research university that fosters excellence and attracts world-class talent to innovate today and prepare leaders for the future. We welcome candidates who can contribute to the diversity and excellence of our academic community.
The Task Force for Global Health (TFGH), based in Atlanta and founded nearly 40 years ago to advance health equity, works with partners in more than 150 countries to eliminate diseases, ensure access to vaccines and essential medicines, and strengthen health systems to protect populations. The Center for Vaccine Equity (CVE) works to assure all people have equal access to life-saving vaccines by expanding availability, supporting vaccine impact studies, and building delivery systems that facilitate access in developing countries. The ultimate goal is to build sustainable national adult vaccination platforms.
For the last two decades, the Brighton Collaboration has built trust in the safety of vaccines through rigorous science. It does this by developing standards [e.g., case definitions for adverse events following immunization (AEFI)/of special interest (AESI)], guidance, protocols, tools and international monitoring approaches for globally harmonized safety assessment of human vaccines (e.g., those in the WHO Expanded Program on Immunizations (EPI), vaccines for pandemic use, and others under development).
SPEAC Project (50%): The Safety Platform for Emergency vACcines (SPEAC) is a BC project funded by the Coalition for Epidemic Preparedness (CEPI). The project supports CEPI’s mission to stimulate and accelerate the development of vaccines against emerging infectious diseases and enable access to these vaccines for people during outbreaks by creating capacity and solutions for harmonized safety assessment of CEPI vaccines. SPEAC 1.0, the first phase of this partnership which began May of 2019 and is funded through August 2022, provided oversight of vaccine safety for all trials, and potentially identifying issues of relevance across priority platforms and pathogens. The mission of SPEAC 2.0 is to provide best available scientific evidence on the safety of CEPI vaccines to support timely benefit-risk assessment during the vaccine life cycle. SPEAC 2.0 will support CEPI 2.0 by providing a harmonized vaccine safety assessment and monitoring service for CEPI and its awardees, in as many geographic regions where emerging pathogen vaccine studies will be conducted as budget permits with a focus on LMIC. It will do this by constantly reviewing and summarizing literature, evidence arising from expert groups and transforming this into educational and operational tools, definitions, guidelines, and best practice for harmonized safety assessment.
CARESAFE Project (30%): Within the context of the CVE’s COVID-19 Vaccine Introduction Program (COVP) in up to 50 low- and middle-income countries (LMIC), funded in February, 2021, the CARESAFE project builds on existing CDC Global Immunization Division (GID)/Global Immunization Safety Team (GIST) and Task Force for Global Health (TFGH)/Brighton Collaboration (BC) platforms and technical expertise to work with 4 LMIC to pilot several, many relatively novel to LMIC, approaches to strengthen their vaccine safety capacity.
Brighton Collaboration Program (20%): In collaboration with the Scientific Director, the Director of Research will develop a strategy for building on the legacy of the Brighton Collaboration and secure funding to strengthen the infrastructure and sustain ongoing efforts. In addition, the Scientific Director will have oversight of the website, staff, and collaborators including the BC Coordinators, volunteers, and science board.
NOTE: This role will be granted the opportunity to work from home temporarily during the COVID-19 pandemic, with intent to return to an Emory University location in the future. Emory reserves the right to change remote work status with notice to employee.
To ensure the safety of our campus community, the COVID-19 vaccine is required. For more information on the University and Hospital policies and potential exemptions, please see our website.
Emory University is dedicated to providing equal opportunities and equal access to all individuals regardless of race, color, religion, ethnic or national origin, gender, genetic information, age, disability, sexual orientation, gender identity, gender expression, and veteran's status. Emory University does not discriminate in admissions, educational programs, or employment on the basis of any factor stated above or prohibited under applicable law. Students, faculty, and staff are assured of participation in University programs and in the use of facilities without such discrimination. Emory University complies with Executive Order 11246, as amended, Section 503 of the Rehabilitation Act of 1973, the Vietnam Era Veteran's Readjustment Assistance Act, and applicable executive orders, federal and state regulations regarding nondiscrimination, equal opportunity and affirmative action. Emory University is committed to achieving a diverse workforce through application of its affirmative action, equal opportunity and nondiscrimination policy in all aspects of employment including recruitment, hiring, promotions, transfers, discipline, terminations, wage and salary administration, benefits, and training. Inquiries regarding this policy should be directed to the Emory University Department of Equity and Inclusion, 201 Dowman Drive, Administration Building, Atlanta, GA 30322.
Emory University is committed to providing reasonable accommodations to qualified individuals with disabilities upon request. To request this document in an alternate format or to request a reasonable accommodation, please contact the Department of Accessibility Services at 404-727-9877 (V) | 404-712-2049 (TDD). Please note that one week advance notice is preferred.